Vapocoolant spray for intravenous cannulation pain: a Prospective, randomized controlled trial
Öz
Introduction: Peripheral intravenous (IV) cannulation are routine procedures in emergency department (ED) admissions. Vapocoolant sprays have a potential advantage over other topical agents.We aimed to see how effective vapocoolant spray was in reducing pain during intravenous cannulation versus a control group in this study.
Materials and Methods: This is a prospective, randomized control study consisting of patients who were admitted to the ED. The study included patients aged 18 and over who applied to the ED and had IV cannulation. The patients were divided into 2 groups as control and vapocoolant spray groups. Age, gender, and dominant hand status of all patient groups were recorded. Side effects were observed after the application. The Visual Analogue Scale (VAS), which is the most widely used scale to measure pain, was used.
Results: 206 individuals were randomized. The mean age of the vapocoolant spray group was 46.40±16.44 years, while it was 46.75±17.49 years for the control group. The vapocoolant spray group was found to have significantly lower mean VAS values during IV cannulation than the control group (1.47±1.32 vs. 3.97±1.97 p<0.001). It was found that the vapocoolant spray-applied group had a significantly lower percentage in terms of moderate pain (VAS>3 cm) compared to the control group (7.8% vs 58.3%, p<0.001). Besides, the percentage of severe pain (VAS>5.4 cm) in the spray-applied group was found to be significantly lower than the control group (1% vs. 20.4%, p<0.001).
Conclusion: The vapocoolant spray can be used effectively to mitigate the pain associated with the pre-IV cannulation procedure and can be an alternative method for reducing pain in emergency departments.
Anahtar Kelimeler
Kaynakça
- 1. Zempsky WT. Pharmacologic approaches for reducing venous access pain inchildren. Pediatrics 2008; 122: 140–53.
- 2. Mura P, Serra E, Marinangeli F, et al. Prospective study on prevalence, intensity, type, and therapy of acute pain in a second-level urban emergency department. J Pain Res 2017; 10: 2781-8.
- 3. Ducharme J. Acute Pain Management in the year 2018-a review. J Acute Med 2018; 8: 53-9.
- 4. Mace SE. Prospective, randomized, double-blind controlled trial comparing vapocoolant spray vs placebo spray in adults undergoing venipuncture. Am J Emerg Med 2016; 34: 798-804. 5. Zempsky WT. Pharmacologic approaches for reducing venous access pain in children. Pediatrics 2008; 122: 140–53.
- 6. Hogan ME, Smart S, Shah V, Taddio A. A systematic review of vapocoolants for reducing pain from venipuncture and venous cannulation in children and adults. J Emerg Med 2014; 47: 736-49.
- 7. Barbour T, O'Keefe S, Mace SE. Patient and health care provider responses from a prospective, double-blind, randomized controlled trial comparing vapocoolant spray versus placebo spray in adults undergoing venipuncture in the emergency department. Pain Manag Nurs. 2018; 19: 391-9.
- 8. Unal N, Tosun B, Aslan O, Tunay S. Effects of vapocoolant spray prior to sc lmwh ınjection: an experimental study. Clinical Nursing Research 2021; 30: 127-34.
- 9. Dalvandi A, Ranjbar H, Hatamizadeh M, Rahgoi A, Bernstein C. Comparing the effectiveness of vapocoolant spray and lidocaine/procaine cream in reducing pain of intravenous cannulation: A randomized clinical trial. Am J Emerg Med 2017; 35: 1064-8.
- 10. Hogan ME, Smart S, Shah V, Taddio A. A systematic review of vapocoolants for reducing pain from venipuncture and venous cannulation in children and adults. J Emerg Med 2014; 47: 736–49.
- 11. Griffith VJ, H D. Vapocoolants for pain treatment during intravenous cannulation. Cochrane Database Syst Rev 2016; 4: 9484.